# Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

> **NCT01915524** · PHASE1 · TERMINATED · sponsor: **CureVac** · enrollment: 26 (actual)

## Conditions studied

- Non-Small Cell Lung Carcinoma

## Interventions

- **BIOLOGICAL:** CV9202
- **RADIATION:** local radiation

## Key facts

- **NCT ID:** NCT01915524
- **Lead sponsor:** CureVac
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time
- **Last updated:** 2016-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915524, "Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01915524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*